Stock listing
ASX:NEU Neuren Pharmaceuticals Limited Share Price
Home listing (ASX) of Neuren Pharmaceuticals Limited
Follow Neuren Pharmaceuticals Limited into a list and get an email when it puts out news.
Share price · ASX:NEU
$20.75 AUD +0.39 (+1.9%)
Close on Nov 2, 2026
- Day range
- $20.03 – $21.48 AUDNov 2, 2026
- Volume
- 459,852 sharesNov 2, 2026
- Market cap
- $2.63B AUDAt the close on Nov 2, 2026 · price × 126.8M shares outstanding
- 52-week range
- $11.00 – $23.76 AUDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $9.82M AUDMedian day 378,801 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:NEU · Home | $20.75 AUD | +0.39 (+1.9%) | 459,852 | $20.36 | $21.48 | $20.03 | $20.36 | Close on Nov 2, 2026 |
| Frankfurt:NK9 | €12.60 EUR | +1.10 (+9.6%) | — | €12.60 | €12.60 | €12.60 | €11.50 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · ASX:NEU · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $20.75 | +0.39 | +1.9% | $20.36 | $21.48 | $20.03 | 459,852 | |
| $20.36 | +0.22 | +1.1% | $20.34 | $20.70 | $20.24 | 285,252 | |
| $20.14 | +1.19 | +6.3% | $19.15 | $20.50 | $18.99 | 401,003 | |
| $18.95 | +0.25 | +1.3% | $18.98 | $19.63 | $18.51 | 358,905 | |
| $18.70 | +0.05 | +0.3% | $18.63 | $18.99 | $18.50 | 445,650 | |
| $18.65 | -0.93 | -4.7% | $19.40 | $19.40 | $18.58 | 444,930 | |
| $19.58 | -0.23 | -1.2% | $19.70 | $19.78 | $19.30 | 284,861 | |
| $19.81 | +0.11 | +0.6% | $19.70 | $19.82 | $19.26 | 347,159 | |
| $19.70 | +0.08 | +0.4% | $20.00 | $20.15 | $19.34 | 304,805 | |
| $19.62 | -0.08 | -0.4% | $19.65 | $19.87 | $19.22 | 246,041 | |
| $19.70 | -0.51 | -2.5% | $19.90 | $20.14 | $19.64 | 245,644 | |
| $20.21 | +1.02 | +5.3% | $19.48 | $20.21 | $19.39 | 303,287 | |
| $19.19 | -0.21 | -1.1% | $19.58 | $19.63 | $18.92 | 432,750 | |
| $19.40 | -0.24 | -1.2% | $19.64 | $19.66 | $18.89 | 441,820 | |
| $19.64 | -0.57 | -2.8% | $20.01 | $20.24 | $19.41 | 309,518 | |
| $20.21 | +0.01 | 0.0% | $20.22 | $20.31 | $19.43 | 311,392 | |
| $20.20 | -0.06 | -0.3% | $20.32 | $20.45 | $20.04 | 258,985 | |
| $20.26 | +0.13 | +0.6% | $20.05 | $20.42 | $19.85 | 198,507 | |
| $20.13 | -0.07 | -0.3% | $20.10 | $20.39 | $19.96 | 305,002 | |
| $20.20 | -0.23 | -1.1% | $20.48 | $20.56 | $19.84 | 315,394 | |
| $20.43 | +0.15 | +0.7% | $20.30 | $20.63 | $19.98 | 210,915 | |
| $20.28 | +0.14 | +0.7% | $20.23 | $20.45 | $20.04 | 192,272 | |
| $20.14 | -0.21 | -1.0% | $20.07 | $20.65 | $19.90 | 361,837 | |
| $20.35 | +0.08 | +0.4% | $20.10 | $20.36 | $19.85 | 473,440 | |
| $20.27 | +0.45 | +2.3% | $19.80 | $20.60 | $19.47 | 326,246 | |
| $19.82 | -0.40 | -2.0% | $20.00 | $20.35 | $19.66 | 315,658 | |
| $20.22 | -0.38 | -1.8% | $20.52 | $20.56 | $19.82 | 277,316 | |
| $20.60 | -0.01 | 0.0% | $20.30 | $20.81 | $20.26 | 295,017 | |
| $20.61 | -0.30 | -1.4% | $20.91 | $21.00 | $20.61 | 241,222 | |
| $20.91 | +0.26 | +1.3% | $20.75 | $20.99 | $20.57 | 241,337 | |
| $20.65 | -0.03 | -0.1% | $20.51 | $21.05 | $20.31 | 304,249 | |
| $20.68 | +0.14 | +0.7% | $20.98 | $21.09 | $20.44 | 586,911 | |
| $20.54 | +0.18 | +0.9% | $20.67 | $21.19 | $20.36 | 533,951 | |
| $20.36 | -0.36 | -1.7% | $20.77 | $20.85 | $19.90 | 438,798 | |
| $20.72 | +0.05 | +0.2% | $20.50 | $21.01 | $20.44 | 356,143 | |
| $20.67 | +0.42 | +2.1% | $20.15 | $20.99 | $20.10 | 396,632 | |
| $20.25 | +0.04 | +0.2% | $19.92 | $20.49 | $19.90 | 399,012 | |
| $20.21 | -0.30 | -1.5% | $19.68 | $20.24 | $19.63 | 628,627 | |
| $20.51 | -0.13 | -0.6% | $20.46 | $20.63 | $20.28 | 229,237 | |
| $20.64 | +0.18 | +0.9% | $20.48 | $20.72 | $20.24 | 205,219 | |
| $20.46 | +0.13 | +0.6% | $20.18 | $20.62 | $20.10 | 240,310 | |
| $20.33 | -0.24 | -1.2% | $20.15 | $20.97 | $20.03 | 901,431 | |
| $20.57 | +0.61 | +3.1% | $20.20 | $20.64 | $19.99 | 299,553 | |
| $19.96 | +0.07 | +0.4% | $19.69 | $20.24 | $19.43 | 610,052 | |
| $19.89 | +0.15 | +0.8% | $19.35 | $19.98 | $19.29 | 474,053 | |
| $19.74 | -0.71 | -3.5% | $20.09 | $20.53 | $19.44 | 941,982 | |
| $20.45 | -0.57 | -2.7% | $20.79 | $20.92 | $20.15 | 597,870 | |
| $21.02 | +0.87 | +4.3% | $20.08 | $21.02 | $19.93 | 702,207 | |
| $20.15 | -2.38 | -10.6% | $22.50 | $22.92 | $20.15 | 796,019 | |
| $22.53 | +0.08 | +0.4% | $23.20 | $23.22 | $22.18 | 727,764 | |
| $22.45 | -0.01 | 0.0% | $22.00 | $22.75 | $21.72 | 362,496 | |
| $22.46 | -0.68 | -2.9% | $22.80 | $23.20 | $22.26 | 552,370 | |
| $23.14 | +0.29 | +1.3% | $23.01 | $23.30 | $22.81 | 769,119 | |
| $22.85 | -0.19 | -0.8% | $23.00 | $23.38 | $22.43 | 575,192 | |
| $23.04 | +0.09 | +0.4% | $22.90 | $23.34 | $22.68 | 500,357 | |
| $22.95 | -0.50 | -2.1% | $23.45 | $23.46 | $22.42 | 503,179 | |
| $23.45 | -0.12 | -0.5% | $23.59 | $23.70 | $23.04 | 362,660 | |
| $23.57 | +0.26 | +1.1% | $23.35 | $23.67 | $23.26 | 743,212 | |
| $23.31 | -0.33 | -1.4% | $23.51 | $23.76 | $23.15 | 394,942 | |
| $23.64 | +0.64 | +2.8% | $22.70 | $23.67 | $22.70 | 717,873 | |
| $23.00 | +0.28 | +1.2% | $22.72 | $23.45 | $22.67 | 779,090 | |
| $22.72 | +1.16 | +5.4% | $21.55 | $22.74 | $21.23 | 790,891 | |
| $21.56 | -0.08 | -0.4% | $21.73 | $22.27 | $21.02 | 1,012,625 | |
| $21.64 | +3.03 | +16.3% | $20.00 | $22.00 | $19.99 | 2,155,548 | |
| $18.61 | +0.02 | +0.1% | $18.50 | $18.92 | $18.45 | 341,729 | |
| $18.59 | +0.59 | +3.3% | $17.86 | $18.59 | $17.40 | 331,788 |
- Ticker
- ASX:NEU
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 1, 2026
FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE
Latest deck · Sep 2, 2026
Investor Presentation (September 2026)
Investor deck · 19 slides
Latest news
FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE
Nov 1, 2026
Closed $20.75 (+1.9%) on Nov 2, 2026
Trofinetide US patent protections extended to March 2041
Sep 28, 2026
Closed $20.27 (+2.3%) on Sep 29, 2026
Growing royalty anchors Neuren first ever dividend program
Aug 25, 2026
Closed $20.15 (-10.6%) on Aug 26, 2026
European Commission grants marketing authorisation for DAYBU
Aug 24, 2026
Closed $22.53 (+0.4%) on Aug 25, 2026
Record Q2 DAYBUE net sales of US$125m, CY26 royalty upgraded
Aug 4, 2026
Closed $21.64 (+16.3%) on Aug 5, 2026
DAYBU recommended for approval in the European Union
Jun 28, 2026
Closed $16.60 (+36.1%) on Jun 29, 2026
Q1 2026 DAYBUE net sales US$101m, up 20% from Q1 2025
May 7, 2026
Closed $13.05 (+5.9%) on May 7, 2026
DAYBUE STIX now broadly available in US for Rett syndrome
Apr 8, 2026
Closed $13.00 (+5.7%) on Apr 8, 2026
Acadia confirms plan to request CHMP re-examination
Mar 2, 2026
Closed $12.56 (-8.8%) on Mar 3, 2026
2025 royalty income A$65m, profit after tax A$30m
Feb 26, 2026
Closed $13.05 (-2.9%) on Feb 27, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 19 slides · Sep 2, 2026
H1 2026 Earnings Presentation
Earnings · 15 slides · Aug 26, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 16 slides · May 27, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 23 slides · May 27, 2026
Neuren Pharmaceuticals Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 257 in all · newest Nov 1, 2026 · oldest 2016
- Decks
- 80 decks · latest Sep 2, 2026
Where Neuren Pharmaceuticals Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:NEU · Home listing · This page | ASX | Australia | AUD |
| OTC:NURPF | OTC | United States | USD |
| Frankfurt:NK9 | Frankfurt | Germany | EUR |
| Stuttgart:NK9 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Neuren Pharmaceuticals Limited.